NEW YORK (GenomeWeb) – In a recent filing with the US Securities and Exchange Commission, CareDx said it intends to offer for sale 3 million of its shares of common stock.

The firm has not yet priced its shares but said the proposed maximum offering price will be $2.72 per share. The proposed maximum aggregate offering price is about $9.4 million, it added.

The firm has also granted the unnamed underwriters a 30-day option to purchase up to 450,000 additional shares of common stock at the public offering price to cover any over-allotments.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.